GleamWall
中文EN

MDNC Medinotec Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1931055 · Fiscal year ends 02/28

Financial factors as of 2026-08-31 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-10.9%
TTM net income YoY-73.4%
TTM EPS YoY-73.4%
Revenue 3-yr CAGR92.4%
Net income 3-yr CAGR—

Margins

Gross margin49.6%
Operating margin6.6%
Net margin5.8%
FCF margin—
EBITDA margin7.6%

Returns

ROE11.1%
ROA9.0%
ROIC (approx.)22.6%
Asset turnover1.53x

Leverage & solvency

Liabilities / assets14.7%
Debt / equity0.00x
Current ratio6.74x
Interest coverage21.76x

Cash quality & payout

Operating cash flow / net income0.63x
Accruals ratio3.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q22026-08-312027Q12026-05-312026Q4*2026-02-282026Q32025-11-302026Q22025-08-312026Q12025-05-312025Q4*2025-02-282025Q32024-11-30
Income statement
Revenue$3.20M$2.65M$1.82M$2.54M$3.24M$2.13M$3.53M$2.57M
Cost of revenue$1.64M$1.34M$967,581$1.19M$1.25M$1.22M-$7.37M$1.52M
Gross profit$1.56M$1.31M$854,557$1.35M$1.98M$913,168$2.39M$1.04M
R&D expense$22,076$7,970$26,283$8,326$66,235$49,014-$177,275$69,270
SG&A expense$835,893$594,286$586,781$435,395$706,597$557,418-$2.40M$379,217
Operating income$202,723$180,872-$264,222$552,712$528,565$277,457$1.96M$527,451
Interest expense$8,620$6,868$8,280$7,116$40,274$31,925$27,909$43,400
Pretax income$180,243$208,499-$273,121$542,714$536,822$262,772$1.92M$481,474
Income tax$139,377—-$753,232$13,515$190,256$148,988-$1.28M$148,988
Net income$40,866$222,014-$69,259$403,411$346,566$113,784$1.48M$310,311
EBITDA$224,547$202,154-$206,018$560,378$536,062$284,963$1.96M$546,657
EPS (basic)0.000.02—0.030.030.01—0.03
EPS (diluted)0.00———0.030.01——
Weighted avg. shares (diluted)11.76M———11.75M———
Balance sheet
Cash & equivalents$2.58M$2.52M$2.76M$2.86M$2.25M$1.95M$2.77M$2.68M
Receivables$2.62M$2.51M$2.35M$2.26M$2.58M$3.89M$2.61M$992,464
Inventory$1.15M$1.43M$1.24M$1.21M$994,074$928,070$988,341$1.15M
Current assets$6.44M$6.57M$6.42M$6.47M$5.98M$6.96M$6.42M$4.92M
PP&E, net$374,808$345,011$331,346$325,916$333,296$344,653$348,486$378,294
Total assets$6.95M$6.99M$6.81M$6.85M$6.37M$7.40M$6.81M$5.36M
Current liabilities$955,281$1.13M$1.10M$1.35M$1.53M$2.09M$1.51M$1.47M
Total liabilities$1.02M$1.13M$1.10M$1.35M$1.53M$3.04M$2.54M$2.54M
Shareholders' equity$5.93M$5.85M$5.71M$5.50M$4.84M$4.37M$4.27M$2.83M
Shares outstanding11.76M11.76M11.76M11.76M11.76M11.76M11.73M11.73M
Cash flow statement
Operating cash flow$107,526-$176,125-$120,641$563,139$1.22M-$759,238$98,715$124,510
Capital expenditure$46,635$40,350————-$1,346$72,626
Free cash flow$60,891-$216,475————$100,061$51,884
Investing cash flow-$46,635-$40,350————$1,346-$72,626
Financing cash flow——$25-$2,531-$942,567-$37,900-$50,927-$109,684
Depreciation & amortization$21,824$21,282$58,204$7,666$7,497$7,506-$657$19,206

Free plan shows the latest 8 periods; Pro shows all 21 🔒

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.